# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-020959
Filing Date
2023-04-27
Accepted
2023-04-27 16:20:38
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | ny20008153x2_defa14a.htm | DEFA14A | 15394
2 |  | ny20008153x2_nc1.jpg | GRAPHIC | 374652
3 |  | ny20008153x2_nc2.jpg | GRAPHIC | 330970
| Complete submission text file | 0001140361-23-020959.txt |  | 988268

Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39696 | Film No.: 23857295
SIC: 2836 Biological Products, (No Diagnostic Substances)